Scholars@Duke

• Expertise
• 

  Subject Headings

  • Allergy and Immunology
  • Immunological adjuvants
  • Vaccines
• Research
• 

  Selected Grants

  • Adjuvant Discovery Program (Option #2) awarded by National Institutes of Health 2014 - 2019
  • Development of a Peanut Allergy Immunotherapy awarded by Molecular Express, Inc. 2017 - 2018
  • Adjuvant Discovery Program (Option #1) awarded by National Institutes of Health 2014 - 2017
• Publications & Artistic Works
• 

  Selected Publications

  • Journal Articles

    • Johnson-Weaver, BT, McRitchie, S, Mercier, KA, Pathmasiri, W, Sumner, SJ, Chan, C, Germolec, D, Kulis, M, Burks, AW, and Staats, HF. "Effect of endotoxin and alum adjuvant vaccine on peanut allergy." The Journal of allergy and clinical immunology 141, no. 2 (February 2018): 791-794.e8.  Full Text
    • Roggelin, L, Vinnemeier, CD, Fischer-Herr, J, Johnson-Weaver, BT, Rolling, T, Burchard, GD, Staats, HF, and Cramer, JP. "Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers." Vaccine 33, no. 33 (August 2015): 4141-4145.  Full Text
    • Gwinn, WM, Johnson, BT, Kirwan, SM, Sobel, AE, Abraham, SN, Gunn, MD, and Staats, HF. "A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen." Vaccine 31, no. 11 (March 1, 2013): 1480-1489.  Full Text  Link to Item
    • Thompson, AL, Johnson, BT, Sempowski, GD, Gunn, MD, Hou, B, DeFranco, AL, and Staats, HF. "Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production." J Immunol 188, no. 6 (March 15, 2012): 2834-2846.  Full Text  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.